Q1 2026 · 13F-HR
EQT Fund Management S.a r.l.holdings as filed
Filed 2026-05-14 · accession 0001193125-26-224227
$1.02B
Reported value
5
Positions
2026-03-31
Period end
The Brief · EQT Fund Management S.a r.l. · Q1 2026
AI · grounded in 13F
EQT Fund Management S.a r.l. established a new position in AGMB with an investment of $53.9M. The fund added one position to its portfolio while reducing none. Total assets under management reached $1.02B across five positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 946784105 | WAY | WAYSTAR HLDG CORP | $599.8M | 58.8% | 24,879,437 | Common | SOLE |
| H5870P102 | OCS | OCULIS HOLDING AG | $156.9M | 15.4% | 5,900,294 | Common | SOLE |
| 30054Y107 | EVMN | EVOMMUNE INC | $113.3M | 11.1% | 4,929,633 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $96.7M | 9.48% | 3,424,609 | Common | SOLE |
| 00860C102 | AGMB | AGOMAB THERAPEUTICS NV | $53.9M | 5.28% | 5,141,992 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.